Evidence map›Paper›PMID 25742473›Full record

ArticleBritish journal of cancer2015

Occupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study.

L Costas, C Infante-Rivard, J-P Zock, M Van Tongeren, P Boffetta, A Cusson, C Robles, D Casabonne, Y Benavente, N Becker and 7 more

Open access · hybridAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 13 institutions in 9 countries.

L Costas1] Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908 Barcelona, Spain [2] Department of Medicine, University of Barcelona, 08036 Barcelona, Spain [3] CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.
C Infante-RivardDepartment of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montréal, QC, Canada H3A 1A2.
J-P Zock1] CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain [2] Netherlands Institute for Health Services Research (NIVEL), 3500 Utrecht, The Netherlands [3] Centre for Research in Environmental Epidemiology (CREAL), 08003 Barcelona, Spain [4] Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.
M Van TongerenCentre for Human Exposure Science (CHES), Institute of Occupational Medicine, EH14 4AP Edinburgh, UK.
P BoffettaTisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, 10029 NY, USA.
A CussonCentre de Recherche, CHU Sainte-Justine, Montréal, QC, Canada H3T 1C4.
C RoblesUnit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908 Barcelona, Spain.
D Casabonne1] Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908 Barcelona, Spain [2] CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.
Y Benavente1] Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908 Barcelona, Spain [2] CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.
N BeckerDivision of Cancer Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
P BrennanIARC, International Agency for Research on Cancer, 69372 Lyon, France.
L ForetovaCancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, 65653 Brno, Czech Republic.
M MaynadiéBiological Hematology Unit, CRB Ferdinand Cabanne, Universitary Hospital of Dijon and EA4184, University of Burgundy, EA 4184 Dijon, France.
A StainesPublic Health University College, Dublin, Ireland.
A NietersCentre of Chronic Immunodeficiency, Molecular Epidemiology, University Medical Center Freiburg, 79106 Freiburg, Germany.
P CoccoDepartment of Public Health, Clinical and Molecular Medicine, Occupational Health Section, University of Cagliari, 09124 Cagliari, Italy.
S de Sanjosé1] Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, 08908 Barcelona, Spain [2] Department of Medicine, University of Barcelona, 08036 Barcelona, Spain [3] CIBER Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESInstitut Català d'Oncologia · ESCentre Hospitalier Universitaire Sainte-Justine · CACentre International de Recherche sur le Cancer · FRHeidelberg University · DEIcahn School of Medicine at Mount Sinai · USInstitute of Occupational Medicine · GBMasaryk Memorial Cancer Institute · CZMcGill University · CAUniversité de Bourgogne · FRUniversity College Dublin · IEUniversity Medical Center Freiburg · DEUniversity of Cagliari · IT

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundIncidence rates of lymphoma are usually higher in men than in women, and oestrogens may protect against lymphoma.

methodsWe evaluated occupational exposure to endocrine disrupting chemicals (EDCs) among 2457 controls and 2178 incident lymphoma cases and subtypes from the European Epilymph study.

resultsOver 30 years of exposure to EDCs compared to no exposure was associated with a 24% increased risk of mature B-cell neoplasms (P-trend=0.02). Associations were observed among men, but not women.

conclusionsProlonged occupational exposure to endocrine disruptors seems to be moderately associated with some lymphoma subtypes.

Indexed as

Case-Control StudiesEndocrine DisruptorsEuropeFemaleHumansIncidenceLymphomaMaleOccupational DiseasesOccupational ExposureRisk FactorsSex FactorsEndocrine Disruptors

Identifiers

PMID25742473
PMCPMC4385964
OpenAlexW1965713922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.